Primary Graft Dysfunction: Clinical Trials

25 trials for Primary Graft Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 7 unknown, 4 terminated, 3 recruiting. 5 Phase 2, 4 Not applicable, 2 Phase 3, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 25Completed 1, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Not applicable4Completed 3, Recruiting 1
Phase 32Unknown 1, Withdrawn 1
Phase 11Completed 1
Phase 41Completed 1

Follow Primary Graft Dysfunction: new trials by email Literature Review of Primary Graft Dysfunction trials Research Report on Primary Graft Dysfunction

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft Dysfunction
Xo Port Organ Preservation System, Standard of Care - Ice packs - Primary Graft Dysfunction
Not applicableRecruitingUniversity Health Network, Toronto502026-04-172026-07-13
This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
Maraviroc, Placebo - Primary Graft Dysfunction, Lung Transplantation
Phase 2RecruitingUniversity of California, San Francisco1202025-12-072026-01-20
Perioperative Vitamin C Lung Transplant
Vitamin C - Primary Graft Dysfunction, Lung Transplant; Complications
Phase 2WithdrawnUniversity of Wisconsin, Madison2023-04-012023-05-01
Observational Study on the Variation of Ascorbic Acid in Patients Undergoing Solid Organ Transplantation
Transplantation, Ascorbic Acid Deficiency
UnknownPoliclinico Hospital402023-02-012024-09-04
Identifying Optimal PEEP After Lung Transplantation
PEEP - Lung Transplant; Complications, Primary Graft Dysfunction
Not applicableCompletedPoliclinico Hospital472023-01-312025-04-02
Biomolecular Phenotyping of Lung Transplant Recipients
Sub-phenotyping by biomarkers concentration - Lung Transplant Failure
CompletedPoliclinico Hospital802022-02-012025-06-18
Lung and Diaphragm Ultrasound in the Early Postoperative Course Following Lung Transplantation
Ultrasound - Lung Transplantation
Not applicableCompletedLudwig-Maximilians - University of Munich702021-04-162022-06-01
Primary Graft Dysfunction, Pronation, Bilateral Lung Transplants
Supine positioning, Early pronation, Late pronation - Lung Transplant, Primary Graft Dysfunction
Not applicableCompletedUniversity of Padova672020-01-012024-02-01
CLAD: Finding Biomarkers to Predict Rejection and/ or Outcome After Lung Transplantation
blood and exhaled breath specimens - Lung Transplant Failure and Rejection, Primary Graft Dysfunction
TerminatedUniversity Hospital, Antwerp242019-10-282024-05-03
Exhaled Breath Particles in Lung Transplantation
Lung Transplant Rejection, Primary Graft Dysfunction
UnknownLund University Hospital1502018-09-182022-05-16
Point-of-care Management of Coagulopathy in Lung Transplantation
Fresh frozen plasma - Lung Transplantation
TerminatedUniversity Hospital, Motol1002018-01-012025-06-10
Bypass vs. Ecmo in Lung Transplantation (BELT)
Extracorporeal Membrane Oxygenation, Cardiopulmonary Bypass - Lung Transplant; Complications
TerminatedThe Cleveland Clinic132017-04-172020-03-24
Lung PGD Biomarkers in Organ Donors
lung biomarkers in organ donor for PGD in lung recipient - Lung Transplant Failure
UnknownUniversity Hospital of Mont-Godinne502017-04-012017-03-24
Heart Transplant and Primary Transplant Dysfunction: a Retrospective Analysis of the Strasbourg Experience
Primary Graft Dysfunction
UnknownUniversity Hospital, Strasbourg, France1002017-01-012018-01-09
Measurement of Extravascular Lung Water to Detect and Predict Primary Graft Dysfunction Following Lung Transplant
Primary Graft Dysfunction
UnknownUniversity Health Network, Toronto602015-10-012018-01-19
Subcutaneous Treprostinil as a Bridge to Lung Transplantation in Severe Pulmonary Hypertension: A Single-Arm Retrospective Study
Subcutaneous Treprostinil - Pulmonary Hypertension, Pulmonary Arterial Hypertension
Phase 4CompletedGuangzhou Institute of Respiratory Disease462015-01-012024-09-23
Pneumoproteins Expression in the Organ Donor
no intervention - Primary Graft Dysfunction
CompletedUniversity Hospital of Mont-Godinne202013-01-012016-03-15
Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft Dysfunction
Sodium Nitrite - Primary Graft Dysfunction
Phase 2TerminatedGladwin, Mark, MD32011-10-012018-08-01
Ex-Vivo Lung Perfusion to Increase the Number of Organs for Transplantation
EVLP Group - Disorder Related to Lung Transplantation, Brain Death
Phase 1CompletedPoliclinico Hospital72011-01-012013-10-23
Quantifying Physical and Biochemical Factors That Contribute to Primary Graft Dysfunction After Lung Transplantation
Primary Graft Dysfunction
UnknownUniversity Hospital, Strasbourg, France452010-07-012011-03-02

Showing 20 of 25. Sign in to see all of them.

Narrower conditions

Heart Failure (2)  ·  Acute Lung Injury (1)  ·  Ascorbic Acid Deficiency (1)  ·  Brain Death (1)  ·  Carcinoma, Hepatocellular (1)  ·  Hemorrhage (1)  ·  Hemostatic Disorders (1)  ·  Hypertension, Pulmonary (1)  ·  Inflammation (1)  ·  Liver Diseases (1)  ·  Liver Failure (1)  ·  Liver Failure, Acute (1)  ·  Liver Neoplasms (1)  ·  Pulmonary Arterial Hypertension (1)

Broader conditions

Cardiovascular Diseases (25)  ·  Pathologic Processes (25)  ·  Pathological Conditions, Signs and Symptoms (25)  ·  Postoperative Complications (25)  ·  Vascular Diseases (25)  ·  Reperfusion Injury (24)  ·  Heart Diseases (2)  ·  Lung Diseases (2)  ·  Respiratory Tract Diseases (2)  ·  Adenocarcinoma (1)  ·  Avitaminosis (1)  ·  Behavior (1)  ·  Brain Diseases (1)  ·  Carcinoma (1)  ·  Central Nervous System Diseases (1)

Interventions

Acetylcysteine (1)  ·  Ascorbic Acid (1)  ·  Blood Specimen Collection (1)  ·  Cardiopulmonary Bypass (1)  ·  Extracorporeal Membrane Oxygenation (1)  ·  Maraviroc (1)  ·  N-monoacetylcystine (1)  ·  Postoperative Period (1)  ·  Sodium Nitrite (1)  ·  Surface-Active Agents (1)  ·  Ultrasonography (1)  ·  calfactant (1)  ·  halofantrine (1)  ·  thymoglobulin (1)

Sponsors

Policlinico Hospital (4)  ·  University Health Network, Toronto (2)  ·  University Hospital of Mont-Godinne (2)  ·  University Hospital, Strasbourg, France (2)  ·  University of Pennsylvania (2)  ·  Azienda Ospedaliera di Padova (1)  ·  Gladwin, Mark, MD (1)  ·  Guangzhou Institute of Respiratory Disease (1)  ·  Ludwig-Maximilians - University of Munich (1)  ·  Lund University Hospital (1)  ·  Rabin Medical Center (1)  ·  The Cleveland Clinic (1)  ·  University Hospital, Antwerp (1)  ·  University Hospital, Motol (1)  ·  University of California, Los Angeles (1)

Countries

Italy (6)  ·  United States (6)  ·  Belgium (2)  ·  Canada (2)  ·  France (2)  ·  Czechia (1)  ·  Germany (1)  ·  Israel (1)  ·  Sweden (1)

Top investigators

Jason D. Christie, MD (2)  ·  Asmae Belhaj, MD, PhD (1)  ·  Daniel Calabrese, MD (1)  ·  Francesco D'Amico, MD (1)  ·  Franco Valenza, MD (1)  ·  Giacomo Grasselli, Porf (1)  ·  John Granton, MD, FRCPC (1)  ·  Julien Pottecher, MD (1)  ·  Matthew Morrell, MD (1)  ·  Micah Long, MD (1)  ·  Michael Tong, M.D., M.B.A. (1)  ·  Miroslav Durila, assoc.prof. (1)  ·  MordechaI R Kramer, Prof (1)  ·  Rajan Saggar, MD (1)  ·  Sandra Lindstedt, MD, PhD (1)

Results publications

PMID 22859317, PMID 23306540, PMID 24467603, PMID 24628890, PMID 27495752, PMID 32591313, PMID 33934981, PMID 36894877, PMID 37734031

NIH funding

R01HL081619 (1), R01HL087115 (1)